Cancer-Associated Fibroblasts in Oncology Research

What Are Cancer-Associated Fibroblasts?

Cancer-associated fibroblasts (CAFs) are one of the major cellular components of the tumor microenvironment. Unlike normal tissue fibroblasts, CAFs adopt activated phenotypes that influence tumor growth, extracellular matrix (ECM) remodeling, immune responses, and therapeutic outcomes.

CAFs are highly heterogeneous. While many originate from resident tissue fibroblasts activated by signals released from tumor and stromal cells, additional populations may arise from mesenchymal stem cells, pericytes, adipocytes, or other stromal precursors. Advances in single-cell sequencing have revealed multiple CAF subpopulations with distinct biological functions, demonstrating that CAFs should not be considered a single, uniform cell type.

Understanding this cellular diversity has become increasingly important for developing physiologically relevant cancer models and identifying new therapeutic targets within the tumor microenvironment.

The Role of CAFs in Tumor Progression

CAFs actively support tumor development through multiple complementary mechanisms.

They produce growth factors that stimulate cancer cell proliferation, remodel the extracellular matrix to facilitate tumor expansion, and alter the metabolic environment to support rapidly growing tumors. By reorganizing collagen fibers and other ECM components, CAFs create structural pathways that promote local tumor invasion and metastatic dissemination.

Beyond their structural functions, CAFs continuously communicate with neighboring cancer cells through soluble signaling molecules, helping establish a tumor microenvironment that favors disease progression.

CAFs and the Tumor Immune Microenvironment

One of the most actively investigated functions of CAFs is their ability to regulate anti-tumor immunity.

Activated CAFs contribute to an immunosuppressive microenvironment by limiting immune cell infiltration into tumors and by producing cytokines and chemokines that influence immune cell recruitment and function. These interactions can reduce the effectiveness of anti-tumor immune responses and may contribute to resistance to immunotherapies in several solid tumors.

Because different CAF subpopulations exhibit distinct immune-regulatory properties, understanding their biological diversity has become a major focus of translational oncology research.

CAFs in Cancer Research Models

The increasing recognition of CAF heterogeneity has driven the development of more physiologically relevant experimental models.

Primary cancer-associated fibroblasts preserve many of the molecular and functional characteristics observed in patient tumors and are widely used to investigate tumor–stroma interactions. Co-culture systems combining CAFs with cancer cells allow researchers to study cell-to-cell communication, while three-dimensional spheroid and organoid models more accurately reproduce the architecture and complexity of the tumor microenvironment.

These advanced in vitro systems provide valuable platforms for studying tumor progression, immune interactions, drug response, and mechanisms of therapeutic resistance.

Primary CAFs and Tumor Stroma Models

Selecting biologically relevant cellular models is essential for translational oncology research.

Preci offers primary cancer-associated fibroblasts together with tumor stroma models and complementary primary oncology cells that support studies of tumor biology, extracellular matrix remodeling, immune interactions, and therapeutic response. These models help researchers investigate the complex cellular communication that drives cancer progression while improving the physiological relevance of preclinical studies.

Conclusion

Cancer-associated fibroblasts are central regulators of the tumor microenvironment and play essential roles in cancer progression, extracellular matrix remodeling, immune modulation, and treatment response. Their remarkable biological diversity makes physiologically relevant experimental models increasingly important for both basic and translational oncology research.

Primary CAF cultures, patient-derived stromal cells, and advanced three-dimensional tumor models provide powerful tools for investigating tumor–stroma interactions and identifying new therapeutic strategies.

Browse cancer cell models and primary oncology cells to support your cancer research at Preci.